BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Boccuto L, Abenavoli L. Genetic and Epigenetic Profile of Patients With Alcoholic Liver Disease. Ann Hepatol. 2017;16:490-500. [PMID: 28612750 DOI: 10.5604/01.3001.0010.0274] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Cacabelos R. Pathoepigenetics: The Role of Epigenetic Biomarkers in Disease Pathogenesis. Pharmacoepigenetics. Elsevier; 2019. pp. 139-89. [DOI: 10.1016/b978-0-12-813939-4.00005-x] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Savić Ž, Vračarić V, Milić N, Nićiforović D, Damjanov D, Pellicano R, Medić-Stojanoska M, Abenavoli L. Vitamin D supplementation in patients with alcoholic liver cirrhosis: a prospective study. Minerva Med 2018;109:352-7. [PMID: 29963831 DOI: 10.23736/S0026-4806.18.05723-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 4.7] [Reference Citation Analysis]
3 European Association for the Study of the Liver. European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of alcohol-related liver disease. J Hepatol. 2018;69:154-181. [PMID: 29628280 DOI: 10.1016/j.jhep.2018.03.018] [Cited by in Crossref: 210] [Cited by in F6Publishing: 169] [Article Influence: 70.0] [Reference Citation Analysis]
4 Colica C, Boccuto L, Abenavoli L. Silymarin: An option to treat non-alcoholic fatty liver disease. World J Gastroenterol 2017; 23(47): 8437-8438 [PMID: 29309065 DOI: 10.3748/wjg.v23.i47.8437] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
5 Abenavoli L, Boccuto L. Nonalcoholic fatty liver disease in obese adolescents: the role of genetic polymorphisms. Hepatobiliary Surg Nutr 2019;8:179-80. [PMID: 31098374 DOI: 10.21037/hbsn.2018.12.03] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Torres JL, Novo-Veleiro I, Manzanedo L, Alvela-Suárez L, Macías R, Laso FJ, Marcos M. Role of microRNAs in alcohol-induced liver disorders and non-alcoholic fatty liver disease. World J Gastroenterol 2018; 24(36): 4104-4118 [PMID: 30271077 DOI: 10.3748/wjg.v24.i36.4104] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 33] [Article Influence: 11.7] [Reference Citation Analysis]
7 Michalak A, Lach T, Cichoż-Lach H. Oxidative Stress-A Key Player in the Course of Alcohol-Related Liver Disease. J Clin Med 2021;10:3011. [PMID: 34300175 DOI: 10.3390/jcm10143011] [Reference Citation Analysis]
8 Tan HK, Yates E, Lilly K, Dhanda AD. Oxidative stress in alcohol-related liver disease. World J Hepatol 2020; 12(7): 332-349 [PMID: 32821333 DOI: 10.4254/wjh.v12.i7.332] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 11.0] [Reference Citation Analysis]
9 Ditano-Vázquez P, Torres-Peña JD, Galeano-Valle F, Pérez-Caballero AI, Demelo-Rodríguez P, Lopez-Miranda J, Katsiki N, Delgado-Lista J, Alvarez-Sala-Walther LA. The Fluid Aspect of the Mediterranean Diet in the Prevention and Management of Cardiovascular Disease and Diabetes: The Role of Polyphenol Content in Moderate Consumption of Wine and Olive Oil. Nutrients 2019;11:E2833. [PMID: 31752333 DOI: 10.3390/nu11112833] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 19.0] [Reference Citation Analysis]
10 Wu L, Zhang Y, Ren J. Epigenetic modification in alcohol use disorder and alcoholic cardiomyopathy: From pathophysiology to therapeutic opportunities. Metabolism 2021;125:154909. [PMID: 34627873 DOI: 10.1016/j.metabol.2021.154909] [Reference Citation Analysis]
11 Abenavoli L, Boccuto L, Federico A, Dallio M, Loguercio C, Di Renzo L, De Lorenzo A. Diet and Non-Alcoholic Fatty Liver Disease: The Mediterranean Way. Int J Environ Res Public Health. 2019;16. [PMID: 31438482 DOI: 10.3390/ijerph16173011] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 19.5] [Reference Citation Analysis]
12 Abenavoli L, Boccuto L. Is possible to detect nonalcoholic fatty liver disease by a new index including single nucleotide polymorphisms (SNPs)? Ann Transl Med 2018;6:366. [PMID: 30370293 DOI: 10.21037/atm.2018.09.20] [Reference Citation Analysis]
13 Kim HG, Cho JH, Kim J, Kim SJ. The Role of Epigenetic Changes in the Progression of Alcoholic Steatohepatitis. Front Physiol 2021;12:691738. [PMID: 34335299 DOI: 10.3389/fphys.2021.691738] [Reference Citation Analysis]